ABP
Abpro CorporationNASDAQHealthcare$0.52+0.00%ClosedMarket Cap: $1.1M
As of 2026-04-04
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.03
P/S
2.35
EV/EBITDA
-0.02
DCF Value
$-16.17
FCF Yield
-3169.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
-55.2%
Operating Margin
-7950.8%
Net Margin
-7670.5%
ROE
83.2%
ROA
-824.3%
ROIC
93.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2025 | $0.00 | -Infinity% | $-1.3M | $-1.7M | $-0.63 | — |
| Q2 2025 | $0.00 | -Infinity% | $-2.3M | $-3.0M | $-1.56 | — |
| Q1 2025 | $0.00 | NaN% | $-3.0M | $-3.9M | $-2.40 | — |
| Q4 2024 | $183.0K | 100.0% | $-8.0M | $-5.5M | $-17.70 | — |
| FY 2024 | $183.0K | 100.0% | $-9.9M | $-7.2M | $-23.10 | — |
| Q3 2024 | $0.00 | Infinity% | $-1.9M | $-335.0K | $-1.07 | — |
| Q2 2024 | $0.00 | -Infinity% | $-2.3M | $-2.4M | $-2.88 | — |
| Q1 2024 | $0.00 | -Infinity% | $-2.9M | $636.0K | $-2.88 | — |
| Q4 2023 | $122.0K | 100.0% | $-10.5M | $-14.5M | $-47.10 | — |
| FY 2023 | $122.0K | 100.0% | $-11.7M | $-11.7M | $-37.50 | — |
| Q3 2023 | $25.0K | 9392.0% | $-2.5M | $-44.6K | $-7.80 | — |
| Q2 2023 | $25.0K | -4728.0% | $-2.7M | $-2.7M | $-8.70 | — |